ConvaTec Group (LON:CTEC) Receives “Buy” Rating from UBS Group

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reaffirmed by stock analysts at UBS Group in a report released on Friday, Marketbeat Ratings reports. They presently have a GBX 375 target price on the stock. UBS Group’s target price would indicate a potential upside of 59.03% from the company’s current price.

CTEC has been the subject of several other research reports. Berenberg Bank cut their target price on ConvaTec Group from GBX 335 to GBX 330 and set a “buy” rating for the company in a research note on Tuesday, August 19th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, July 30th. Peel Hunt reaffirmed a “buy” rating and set a GBX 280 price objective on shares of ConvaTec Group in a research report on Tuesday, October 28th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of ConvaTec Group in a research note on Wednesday, July 30th. Finally, Royal Bank Of Canada raised shares of ConvaTec Group to an “outperform” rating and decreased their target price for the stock from GBX 320 to GBX 315 in a report on Thursday, August 21st. Six research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of GBX 320.33.

ConvaTec Group Stock Performance

CTEC traded up GBX 2.20 during trading hours on Friday, hitting GBX 235.80. The stock had a trading volume of 4,567,398 shares, compared to its average volume of 14,153,500. The company’s fifty day simple moving average is GBX 238.26 and its 200 day simple moving average is GBX 252.97. The stock has a market cap of £4.68 billion, a PE ratio of 22.25, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64. ConvaTec Group has a 1 year low of GBX 213.40 and a 1 year high of GBX 311.20. The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32.

Insider Transactions at ConvaTec Group

In other news, insider Jonny Mason acquired 50,000 shares of ConvaTec Group stock in a transaction that occurred on Thursday, August 28th. The shares were bought at an average cost of GBX 235 per share, with a total value of £117,500. 0.94% of the stock is currently owned by corporate insiders.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.